Wolfgang Brandt

Title: Wolfgang Brandt: Innovator in Dipeptidyl Peptidase IV Research

Introduction

Wolfgang Brandt is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of dipeptidyl peptidase IV (DP IV). His work has implications for understanding substrate specificity and potential treatments for various disorders.

Latest Patents

Wolfgang Brandt holds a patent related to the secondary binding site of dipeptidyl peptidase IV. The patent discusses the relationship between this binding site and substrates, as well as the modulation of substrate specificity of DP IV. It also covers compounds that bind to this secondary site and their applications in treating DP IV mediated disorders. The patent outlines methods for identifying secondary binding sites on DP IV and similar enzymes.

Career Highlights

Throughout his career, Wolfgang Brandt has worked with prominent companies in the pharmaceutical industry. He has been associated with Osi Pharmaceuticals, Inc. and Prosidion Limited, where he contributed to research and development efforts in biochemistry and pharmacology.

Collaborations

Wolfgang Brandt has collaborated with several professionals in his field, including Kerstin Kühn-Wache and Joachim Bär. These collaborations have likely enhanced his research and contributed to the advancement of knowledge in the area of dipeptidyl peptidase IV.

Conclusion

Wolfgang Brandt's innovative work in the field of dipeptidyl peptidase IV research highlights his contributions to biochemistry and potential therapeutic applications. His patent and collaborations reflect his commitment to advancing scientific understanding and treatment options.